CELL & GENE: Immunotherapy For Glioblastoma: A Path Forward

Back Bay advisors are experts in oncology development and advances. Peter Bak and Leah Strickling teamed up to explore the promise and path ahead for IO in a much needed area, Glioblastoma.

While immunotherapy has revolutionized treatment of many types of cancer, it’s promise in GMB is yet to emerge. Leah’s article provides an overview of the intervention types trialed in GBM, and current approaches as a path forward for the treatment.